In this section
HelixTalk
In this section
This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
How Do I Listen?
HelixTalk is available via , by , subscribing to our mailing list, or by listening to any episode in your browser (below).
HelixTalk Episodes
HelixTalk #189 - Mice, Macrophages, and Metabolism: Browning Keeps Obesity at Bay
Date posted: April 7, 2025, 8:35 am
In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid’s research involves the IER3 gene, which is an important modulator of the body’s inflammatory response via its action in major immune cells, including macrophages and T-cells, and plays a role in metabolic disorders such as obesity, diabetes, and atherosclerosis, revealing a previously unknown function of this protein.
HelixTalk #188 - The Clot Thickens: Key Updates from the 2025 Acute Coronary Syndromes Guidelines
Date posted: March 14, 2025, 1:41 pm
In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendations for analgesics, P2Y12 inhibitors, parenteral anticoagulation, and lipid management.
HelixTalk #187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
Date posted: January 23, 2025, 2:47 pm
In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the Â鶹ӰÒôMS College of Pharmacy, about her career path from a pharmacy resident, emergency medicine specialist, infectious diseases specialist, and now a medical sciences liaison.
The views, thoughts, and opinions expressed in this podcast are solely Dr. Anderson’s own and do not necessarily reflect the views, positions, or policies of her employer. This podcast is conducted in a personal capacity, and any reference to her professional background is for context only.
HelixTalk #186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss
Date posted: December 12, 2024, 2:43 pm
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, and safety aspects of these “compounded” GLP-1 receptor agonist medications.